Evaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia.
about
Hemoglobin variability does not predict mortality in European hemodialysis patients.[Profile of chronic renal failure in diabetes at initiation of hemodialysis in the nephrology and dialysis service of the military hospital in Rabat, Morocco].Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011
P2860
Evaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Evaluation and determinants of ...... ialysis patients with anaemia.
@en
Evaluation and determinants of ...... ialysis patients with anaemia.
@nl
type
label
Evaluation and determinants of ...... ialysis patients with anaemia.
@en
Evaluation and determinants of ...... ialysis patients with anaemia.
@nl
prefLabel
Evaluation and determinants of ...... ialysis patients with anaemia.
@en
Evaluation and determinants of ...... ialysis patients with anaemia.
@nl
P2093
P2860
P356
P1433
P1476
Evaluation and determinants of ...... ialysis patients with anaemia.
@en
P2093
Cécile Couchoud
Emmanuel Villar
Luc Frimat
Nathalie Thilly
Stéphanie Boini
P2860
P304
P356
10.1159/000112914
P577
2008-01-08T00:00:00Z